OKYO

OKYO Pharma Ltd ADR is a London-based preclinical biopharmaceutical company specializing in innovative therapies for inflammatory eye diseases and ocular pain. The company is committed to addressing critical unmet medical needs in the ophthalmology sector through its advanced research and development efforts. With a strategically focused pipeline, OKYO Pharma is poised to significantly impact ocular therapeutics and enhance the quality of life for patients suffering from debilitating eye conditions. As it navigates the complexities of drug development, the company's dedication to scientific excellence positions it favorably for future growth within this specialized market.